XClose

UCL Design Language

Home

A nascent retina, generated from a 3D embryonic stem cell culture

Menu
Contents
Metadata
Published
Display
per page
Located
km
Within

11 - 20 of 114 search results for !padrenullquery -UclCommunicationType:"announcement" UclOrgUnit:"cancer institute"

Results

  1. Detecting the (almost) undetectable: new cancer alliance | UCL Cancer …

    https://www.ucl.ac.uk/cancer/news/2019/oct/detecting-almost-undetectable-new-cancer-alliance

    21 Oct 2019: UCL research teams are part of a new transatlantic research alliance to develop radical new strategies and technologies to detect cancer at its earliest stage.

    UCL research teams are part of a new transatlantic research alliance to develop radical new strategies and technologies to detect cancer at its earliest stage.

  2. Athena SWAN Silver Award success | UCL Cancer Institute - UCL -…

    https://www.ucl.ac.uk/cancer/news/2019/oct/athena-swan-silver-award-success

    10 Oct 2019: UCL Cancer Institute has successfully renewed its Athena SWAN Silver status in recognition of our commitment to equality, diversity and inclusion.

    UCL Cancer Institute has successfully renewed its Athena SWAN Silver status in recognition of our commitment to equality, diversity and inclusion.

  3. Secrets of lung cancer spread found in patients’ blood and biopsies | …

    https://www.ucl.ac.uk/cancer/news/2019/oct/secrets-lung-cancer-spread-found-patients-blood-and-biopsies

    8 Oct 2019: Early signs that a patient’s lung cancer may spread and become untreatable can be picked up in samples of their blood and tumour, according to a trio of papers co-led by UCL.

    Early signs that a patient’s lung cancer may spread and become untreatable can be picked up in samples of their blood and tumour, according to a trio of papers co-led by UCL.

  4. Method discovered to reactivate tumour fighting genes ‘silenced’ by…

    https://www.ucl.ac.uk/cancer/news/2019/sep/method-discovered-reactivate-tumour-fighting-genes-silenced-cancer

    27 Sep 2019: Scientists at UCL have developed a method to reactivate ‘tumour suppressor’ genes, which are switched off by cancer cells – a finding which could lead to new targeted biotherapies for cancer.

    Scientists at UCL have developed a method to reactivate ‘tumour suppressor’ genes, which are switched off by cancer cells – a finding which could lead to new targeted biotherapies for cancer.

  5. New CAR T-cell therapy for leukaemia associated with fewer harmful…

    https://www.ucl.ac.uk/cancer/news/2019/sep/new-car-t-cell-therapy-leukaemia-associated-fewer-harmful-side-effects

    7 Sep 2019: A novel CAR T-cell therapy, developed by UCL researchers and designed to target cancer cells more quickly and cause fewer side effects, has shown very promising results for children with previously incurable acute lymphoblastic leukaemia (ALL).

    A novel CAR T-cell therapy, developed by UCL researchers and designed to target cancer cells more quickly and cause fewer side effects, has shown very promising results for children with previously incurable acute lymphoblastic leukaemia (ALL).

  6. Blood test benefits for poor prognosis lung cancer patients | UCL…

    https://www.ucl.ac.uk/cancer/news/2019/sep/blood-test-benefits-poor-prognosis-lung-cancer-patients

    6 Sep 2019: A clinical study, published today in the European Journal of Cancer, finds that VeriStrat testing could help improve the clinical management of advanced non-small cell lung cancer (NSCLC) patients who are considered unsuitable for chemotherapy.

    A clinical study, published today in the European Journal of Cancer, finds that VeriStrat testing could help improve the clinical management of advanced non-small cell lung cancer (NSCLC) patients who are considered unsuitable for chemotherapy.

  7. Resurrecting sentinels in the skin | UCL Cancer Institute - UCL -…

    https://www.ucl.ac.uk/cancer/news/2019/aug/resurrecting-sentinels-skin

    28 Aug 2019: A research team led by Dr Clare Bennett has shown how damaged Langerhans cells in the skin can be replenished by monocytes in order to preserve essential immune function.

    A research team led by Dr Clare Bennett has shown how damaged Langerhans cells in the skin can be replenished by monocytes in order to preserve essential immune function.

  8. SHOC of the new: Targeting SHOC2 in RAS mutant cancers | UCL Cancer…

    https://www.ucl.ac.uk/cancer/news/2019/aug/shoc-new-targeting-shoc2-ras-mutant-cancers

    7 Aug 2019: UCL-led research has identified a promising target that could open up new ways to tackle some of the most common cancers.

    UCL-led research has identified a promising target that could open up new ways to tackle some of the most common cancers.

  9. Pairing drugs for breast and lung cancer could overcome treatment…

    https://www.ucl.ac.uk/cancer/news/2019/jul/pairing-drugs-breast-and-lung-cancer-could-overcome-treatment-resistance

    12 Jul 2019: Targeted drugs for breast and lung cancer could be used together to overcome resistance to treatment in several different tumour types, finds a new study by UCL and The Institute of Cancer Research.

    Targeted drugs for breast and lung cancer could be used together to overcome resistance to treatment in several different tumour types, finds a new study by UCL and The Institute of Cancer Research.

  10. 'War in the Blood', a film about treating cancer patients with CAR T…

    https://www.ucl.ac.uk/cancer/news/2019/jul/war-blood-film-about-treating-cancer-patients-car-t-cell-therapy

    2 Jul 2019: A new BBC film looks at the work of scientists at UCL and clinicians at UCLH working together on groundbreaking ‘first in-human’ immunotherapy trials.

    A new BBC film looks at the work of scientists at UCL and clinicians at UCLH working together on groundbreaking ‘first in-human’ immunotherapy trials.

Pagination

Refine

Subjects

Organisational Units

Communication types

Audiences